Advanced Biological Laboratories has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis.
Abbott will utilize its expertise in infectious disease diagnostics to offer ABL products for HIV genotyping, and facilitate access to the newest and up-to-date analysis of HIV genotyping to its customers in the United States.
For further deal information visit Current Agreements (subscription required)
Report: Partnering Deals and Alliances with Abbott Labs
Report: HIV Partnering 2009-2014
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Partnering Scorecard in CP Insight– view top life science partnering deals by value
View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making
View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity